Fundraising FoxBaruch Future Ventures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Codexis provides enzyme engineering and biocatalysis services for RNA and small molecule API manufacturing, offering RNAi/siRNA and enzymatic synthesis solutions to pharmaceutical partners.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechRedwood City, US
Gordon Sangster(Executive Officer)inJohn Nicols(Executive Officer, Director)inDavid Smith(Director)
BoardThomas Baruch(Director)Pam Cheng(Director)Kathleen Glaub(Director)in
Co-investorsFirstMark Capital
Calysta produces protein ingredients through a patented fermentation platform that does not use arable land, plants, or animal products, offering products such as FeedKind and Positive Protein for animal feed and food.
AgTechBiotechFoodTechMenlo Park, US
Alan Shaw, Ph.D.(President, CEO and Co-Founder)Alan Shaw(President, Chief Executive Officer and Co-Founder)inAlan Shaw, PhD(Founder)inLori Giver(Chief Science and Sustainability Officer)inCraig Barratt, Ph.D.(Director)David Hayes(Director)
Co-investorsAqua SparkCelesta CapitalPangaea Ventures Us Inc.SQN Venture Partners, LLCWestern Technology Investmentbp ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.